Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | RORA | P35398 | 1/20 | 0.42 |
| ▸ | RORC | P51449 | 1/20 | 0.42 |
| ▸ | RORB | Q92753 | 1/20 | 0.42 |
| ▸ | GPR3 | P46089 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15848797 | 1.00 | PTPN1 (0.45) | PTPN1MAPTCYP1A2CYP2D6CYP2C19 | |
| SCHEMBL15848809 | 1.00 | PTPN1 (0.45) | PTPN1MAPTCYP1A2CYP2D6CYP2C19 | |
| SCHEMBL15848810 | 1.00 | PTPN1 (0.45) | PTPN1MAPTCYP1A2CYP2D6CYP2C19 | |
| SCHEMBL15848796 | 1.00 | PTPN1 (0.45) | PTPN1MAPTCYP1A2CYP2D6CYP2C19 | |
| SCHEMBL15848806 | 1.00 | PTPN1 (0.45) | PTPN1MAPTCYP1A2CYP2D6CYP2C19 | |
| SCHEMBL15848795 | 1.00 | PTPN1 (0.45) | PTPN1MAPTCYP1A2CYP2D6CYP2C19 | |
| SCHEMBL15848808 | 1.00 | PTPN1 (0.45) | PTPN1MAPTCYP1A2CYP2D6CYP2C19 | |
| SCHEMBL15848807 | 1.00 | PTPN1 (0.45) | PTPN1MAPTCYP1A2CYP2D6CYP2C19 | |
| SCHEMBL13562219 | 0.99 | PTPN1 (0.46) | PTPN1MAPTCYP1A2CYP2D6CYP2C19 | |
| SCHEMBL13562218 | 0.95 | PTPN1 (0.49) | PTPN1MAPTCYP1A2CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8766243-B2 | Heterocycle-containing asymmetric aromatic compound, compound for organic thin film transistor, and organic thin film transistor using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-07-01 | — | — | US | disclosed |
| US-20120273768-A1 | HETEROCYCLE-CONTAINING ASYMMETRIC AROMATIC COMPOUND, COMPOUND FOR ORGANIC THIN FILM TRANSISTOR, AND ORGANIC THIN FILM TRANSISTOR USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120273768-A1 | HETEROCYCLE-CONTAINING ASYMMETRIC AROMATIC COMPOUND, COMPOUND FOR ORGANIC THIN FILM TRANSISTOR, AND ORGANIC THIN FILM TRANSISTOR USING THE SAME | TCF4, TPR, H1-4 | PTPN1 3685/4885MAPT 391/4885CYP1A2 160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.